1-8 of 8
Consuelo Cañizo
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Is Azacitidine (AZA) Really Effective in High Risk MDS Patients with Chromosome 7 Abnormalities (Abn 7)? Results of a Retrospective Study From the GFM and GESMD Registries

María Díez-Campelo, MD, PhD, Raphael Itzykson, Silvia M Rojas, Céline Berthon, MD, PhD, Elisa Luño, Odile Beyne-Rauzy, Jaime Perez-Oteyza, Norbert Vey, MD, PhD, Joan Bargay, Sophie Park, Teresa Cedena, Dominique Bordessoule, MD, PhD, Juan A Muñoz, Emmanuel Gyan, MD, PhD, Esperanza Such, Sorin Visanica, MD, Luis Benlloch, Stéphane de Botton, MD, PhD, Jesús M Hernández-Rivas, Shanti Ame, MD, Aspasia Stamatoullas, MD, Jacques Delaunay, MD, Celia Salanoubat, MD, Françoise Isnard, MD, Guillermo Sanz, Romain Guieze, MD, Consuelo Cañizo, MD, PhD, Pierre Fenaux, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 1713.
https://doi.org/10.1182/blood.V120.21.1713.1713
Published: 2012
Journal Articles

Prognostic Impact of the Number of Methylated Genes in Myelodysplastic Syndromes and Acute Myeloid Leukemias Treated with 5-Azacytidine

María Abáigar, Fernando Ramos, MD, PhD, MPH, Rocío Benito, PhD, María Díez-Campelo, MD, PhD, Javier Sánchez-del-Real, MD, Lourdes Hermosin, MD, Juan N Rodríguez, MD, Carlos Aguilar, MD, Isabel Recio, MD, Jose M Alonso, MD, Natalia de-las-Heras, MD, Marta Megido, MD, Marta Fuertes, MD, Consuelo Cañizo, MD, PhD, Jesús M Hernández, MD, PhD, Jesús F San Miguel, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 1717.
https://doi.org/10.1182/blood.V120.21.1717.1717
Published: 2012
Journal Articles

Effect of 5-Azacytidine (5-AzaC) In the Expression of PRAME In Acute Myeloid Leukemia (AML)

Silvia Gutiérrez Cosío, Esteban Ballestar, Carlos Santamaría, Belen Blanco, Luis Ignacio Sánchez Abarca, Teresa Caballero Velázquez, Carmen Herrero Sánchez, Soraya Carrancio, Laura Ciudad, Consuelo Cañizo, Jesus F San Miguel, Jose Antonio Pérez Simón
Journal: Blood
Blood (2010) 116 (21): 3615.
https://doi.org/10.1182/blood.V116.21.3615.3615
Published: 2010
Journal Articles

The Novel Combination of Sirolimus and Bortezomib Prevents Graft-Versus-Host Disease but Mantains the Graft-Versus-Leukemia Effect After Allogeneic Transplantation.

Teresa Caballero-Velazquez, Luis Ignacio Sanchez-Abarca, Belen Blanco, Carmen Herrero, Silvia Gutierrez-cosio, Soraya Carrancio, Concepcion Rodriguez-Serrano, Consuelo Cañizo, Jesus F San Miguel, Jose Antonio Perez-Simon
Journal: Blood
Blood (2010) 116 (21): 3738.
https://doi.org/10.1182/blood.V116.21.3738.3738
Published: 2010
Journal Articles

Effect of Demethylating Agents (5-Azacytidine/5-AzaC) On the Immune Response

Silvia Gutiérrez Cosío, Esteban Ballestar, Carlos Santamaría, Belén Blanco, Luis Ignacio Sánchez Abarca, Teresa Caballero Velázquez, Carmen Herrero Sánchez, Soraya Carrancio, Laura Ciudad, Consuelo Cañizo, Jesus F San Miguel, Jose Antonio Pérez Simón
Journal: Blood
Blood (2010) 116 (21): 2771.
https://doi.org/10.1182/blood.V116.21.2771.2771
Published: 2010
Journal Articles

Long-Term Follow up of Healthy Donors Receiving G-CSF for Peripheral Blood Progenitor Cell Mobilization and Collection.

Javier de la Rubia, MD, Concha Zamora, MD, Andres Insunza, MD, Consuelo Cañizo, MD, Cristina Arbona, MD, Miguel A. Díaz, MD, Felipe de Arriba, MD, Carmen Paniagua, MD, Dobleta Martínez, MD, Miguel A. Sanz, MD
Journal: Blood
Blood (2005) 106 (11): 1975.
https://doi.org/10.1182/blood.V106.11.1975.1975
Published: 2005
Journal Articles

Impact of CD34 + cell dose on the outcome of patients undergoing reduced-intensity-conditioning allogeneic peripheral blood stem cell transplantation

José A. Pérez-Simón, María Díez-Campelo, Rodrigo Martino, Anna Sureda, Dolores Caballero, Consuelo Cañizo, Salut Brunet, Albert Altes, Lourdes Vazquez, Jordi Sierra, Jesús F. San Miguel
Journal: Blood
Blood (2003) 102 (3): 1108–1113.
https://doi.org/10.1182/blood-2002-11-3503
Published: 2003
Journal Articles

Early immunophenotypical evaluation of minimal residual disease in acute myeloid leukemia identifies different patient risk groups and may contribute to postinduction treatment stratification

Clinical Trials & Observations
Jesús F. San Miguel, Marı́a B. Vidriales, Consuelo López-Berges, Joaquı́n Dı́az-Mediavilla, Norma Gutiérrez, Consuelo Cañizo, Fernando Ramos, Marı́a J. Calmuntia, José J. Pérez, Marcos González, Alberto Orfao
Journal: Blood
Blood (2001) 98 (6): 1746–1751.
https://doi.org/10.1182/blood.V98.6.1746
Published: 2001